Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Drugs and smoking.

¹College of Pharmacy, University of Iowa, 115 S Grand, Room 118, Building PHAR, Iowa City, IA 52242, USA.

The Journal of Gender-Specific Medicine : JGSM : the Official Journal of the Partnership for Women'S Health at Columbia

|March 17, 2001

Summary

Smokers often require higher drug doses due to altered metabolism, particularly involving the CYP 1A2 enzyme system. Close monitoring is crucial when patients take interacting medications, as smoking impacts drug efficacy and patient response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transduction of E13 murine neural precursor cells by non-immunogenic recombinant adeno-associated viruses induces major changes in neuronal phenotype.

Neuroscience·2012

Same author

Prodynorphin processing by rat CNS fractions and purified enzymes: Formation of Dynorphin A 1-8 by sulfhydryl-activated carboxypeptidase and peptidyl dipeptidase.

Neurochemistry international·2010

Same author

Separate metabolic pathways for Leu-enkephalin and Met-enkephalin-Arg(6)-Phe(7) degradation by rat striatal synaptosomal membranes.

Neurochemistry international·2010

Same author

Evidence for conversion of N-Tyr-MIF-1 into MIF-1 by a specific brain aminopeptidase.

Neurochemistry international·2010

Same author

Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.

Neurology·2008

Same author

Opposite effects of lithium on proximal and distal caspases of immature and mature primary neurons correlate with earlier paradoxical actions on viability.

Neurochemical research·2002

Area of Science:

Pharmacology
Drug Metabolism
Clinical Pharmacy

Background:

Smoking significantly influences drug pharmacokinetics and pharmacodynamics.
The cytochrome P450 1A2 (CYP 1A2) enzyme system is a primary pathway for metabolizing many drugs.
Smokers consume more medications than non-smokers, necessitating a thorough understanding of smoking's impact on drug therapy.

Purpose of the Study:

To elucidate the multifaceted effects of smoking on drug metabolism and patient response.
To highlight the clinical implications of altered drug metabolism in smokers.
To emphasize the importance of considering smoking status in medication management.

Main Methods:

Review of pharmacokinetic studies analyzing drug metabolism in smokers.
Examination of the role of CYP 1A2 in smoking-related drug interactions.
Consideration of non-metabolic factors influencing drug response in smokers, such as protein binding and absorption.

Main Results:

Smoking, particularly via CYP 1A2 induction, often necessitates increased drug dosages.
Inhibition or induction of CYP 1A2 by co-administered drugs requires careful patient monitoring.
Smoking affects drug response through mechanisms beyond hepatic metabolism, including altered protein binding and absorption rates.

Conclusions:

Smoking is a critical factor influencing drug metabolism and efficacy, impacting nearly a quarter of the U.S. adult population.
Clinical practice must account for smoking status to optimize drug therapy and patient outcomes.
Further research, including sex/gender-specific analyses, is vital for comprehensive understanding and management.

Related Experiment Videos